These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1621593)

  • 1. [Vitreous oxygen tension of proliferative diabetic retinopathy].
    Maeda N; Tano Y; Ikeda T; Imai T; Hamano H; Manabe R
    Nippon Ganka Gakkai Zasshi; 1992 Apr; 96(4):511-5. PubMed ID: 1621593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular oxygen tension in eyes with proliferative diabetic retinopathy with and without vitreous.
    Maeda N; Tano Y
    Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S66-9. PubMed ID: 8871152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of vitreous oxygen tension in human eyes.
    Sakaue H; Tsukahara Y; Negi A; Ogino N; Honda Y
    Jpn J Ophthalmol; 1989; 33(2):199-203. PubMed ID: 2761114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraocular oxygen distribution in advanced proliferative diabetic retinopathy.
    Lange CAK; Stavrakas P; Luhmann UFO; de Silva DJ; Ali RR; Gregor ZJ; Bainbridge JWB
    Am J Ophthalmol; 2011 Sep; 152(3):406-412.e3. PubMed ID: 21723532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neovascularization and surgery].
    Tano Y
    Nippon Ganka Gakkai Zasshi; 1990 Dec; 94(12):1122-47. PubMed ID: 2082733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygen tension in the rabbit lens and vitreous before and after vitrectomy.
    Barbazetto IA; Liang J; Chang S; Zheng L; Spector A; Dillon JP
    Exp Eye Res; 2004 May; 78(5):917-24. PubMed ID: 15051473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of PO2 during vitrectomy for central retinal vein occlusion, a pilot study.
    Williamson TH; Grewal J; Gupta B; Mokete B; Lim M; Fry CH
    Graefes Arch Clin Exp Ophthalmol; 2009 Aug; 247(8):1019-23. PubMed ID: 19347349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower intraocular oxygen tension in diabetic patients: possible contribution to decreased incidence of nuclear sclerotic cataract.
    Holekamp NM; Shui YB; Beebe D
    Am J Ophthalmol; 2006 Jun; 141(6):1027-32. PubMed ID: 16765670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
    Itakura H; Kishi S; Kotajima N; Murakami M
    Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preretinal partial pressure of oxygen gradients before and after experimental pars plana vitrectomy.
    Petropoulos IK; Pournaras JA; Stangos AN; Pournaras CJ
    Retina; 2013 Jan; 33(1):170-8. PubMed ID: 22972446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
    Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
    Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
    Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H
    J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitreous levels of reactive oxygen species in proliferative diabetic retinopathy.
    Yeh PT; Yang CM; Huang JS; Chien CT; Yang CH; Chiang YH; Shih YF
    Ophthalmology; 2008 Apr; 115(4):734-737.e1. PubMed ID: 18177940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of vitreous oxygen tension in human and rabbit eyes.
    Sakaue H; Negi A; Honda Y
    Invest Ophthalmol Vis Sci; 1989 Sep; 30(9):1933-7. PubMed ID: 2777513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
    Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
    Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in retinal neovascular tissue and vitreous humour in patients with type 1 and type 2 diabetes.
    Kinnunen K; Puustjärvi T; Teräsvirta M; Nurmenniemi P; Heikura T; Laidinen S; Paavonen T; Uusitalo H; Ylä-Herttuala S
    Br J Ophthalmol; 2009 Aug; 93(8):1109-15. PubMed ID: 19304585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic shift in vitreous after vitrectomy in patients with proliferative diabetic retinopathy.
    Yoshida S; Nakama T; Ishikawa K; Arima M; Tachibana T; Nakao S; Sassa Y; Yasuda M; Enaida H; Oshima Y; Kono T; Ishibashi T
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6997-7003. PubMed ID: 22977138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of regional retinal photocoagulation on vitreal oxygen tension.
    Alder VA; Cringle SJ; Brown M
    Invest Ophthalmol Vis Sci; 1987 Jul; 28(7):1078-85. PubMed ID: 3596988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.